International Journal of Endocrinology and Metabolism
Hossein Piri1, Bahram Kazemi3, Mohsen Rezaei1, Mojgan Bandehpour3, Iraj Khodadadi1, Taghi Hassanzadeh1, Jamshid Karimi1, Fatemeh Yarian3, Habibollah Peirovi4, Amir Hossein Tavakoli5, 
Mohammad Taghi Goodarzi6,*Type 1 diabetes mellitus is one of the metabolic diseases that cause insulin-producing pancreatic cells be destroyed by immune system self-reactive T cells. Recently, new treatment methods have been developed including use of the stem cells, islet cells transplantation and gene therapy by viral and non-viral gene constructs.
The aim of this project was preparing the non-viral vector containing the glucose inducible insulin gene and using it in the NIH3T3 cell line.
Cloning was carried out by standard methods. Total RNA was extracted from pancreatic tissue, RNA was converted to cDNA using RT-PCR reaction and preproinsulin gene was amplified using specific primers. PNMTCH plasmid was extracted and digested by NotI, HindIII, and MTIIA and ChoRE genes were purified and cloned into pcDNA3.1 (-) plasmid and named pcDNAMTCh. Finally, the preproinsulin genes were cloned into pcDNA3.1 (-) plasmid and pcDNAMTChIns was built.
The cloned gene constructs were evaluated by restriction enzyme digestion and RT-PCR. The NIH3T3 cells were transfected by plasmid naked DNA containing preproinsulin gene and expression was confirmed by Reverse Transcriptase PCR and Western Blotting Techniques.
Gel electrophoresis of PCR products confirmed that cloning was performed correctly. The expression of preproinsulin gene in recombinant plasmid in NIH3T3 cell line was observed for the first time. The findings in this study can be the basis of further research on diabetes mellitus type 1 gene therapy on animals.
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Gheflat S, Sadeghi A, Bandehpour M, Ramezani K, Kazemi B. Designing an Engineered Construct Gene Sensitive to Carbohydrate In-vitro and Candidate for Human Insulin Gene Therapy In-vivo. Iran J Pharm Res. 2019;18(4):e124706. doi: https://doi.org/10.22037/ijpr.2019.14650.12567
Soltanmohammadi B, Jalali-Javaran M, Rajabi-Memari H, Mohebodini M. Cloning, Transformation and Expression of Proinsulin Gene in Tomato (Lycopersicum esculentum Mill.). Jundishapur J Nat Pharm Prod. 2014;9(1):9-15. doi: https://doi.org/10.17795/jjnpp-7779
Nasr R, Akbari Eidgahi MR, RezaPorJavaShak AS, Bandegi AR, ValiZadeh S. Construction of pcDNA3.1-FSHβ expression vector in order to transfer FSHβ gene into a mammalian cellline. koomesh. 2013;14(4):e152591. doi:
Baghani A, Youssefi M, Safdari H, Teimourpour R, Meshkat Z. Designing and Construction Pcdna3.1 Vector Encoding Cfp10 Gene of Mycobacterium tuberculosis. Jundishapur J Microbiol. 2015;8(10):e23560. doi: https://doi.org/10.5812/jjm.23560
Mohammadzadeh M, Habibi Roudkenar M. Cloning and transient over-expression of the NRF2 gene in mesenchymal stem cells using adenoviral expression system based on the Gateway technology. J Kermanshah Univ Med Sci. 2013;17(5):e77056. doi:
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):
